DNA cross-linking, double-strand breaks, and apoptosis in corneal endothelial cells after a single exposure to mitomycin C

Investigative Ophthalmology and Visual Science

Volumn 49, Issue 11, 2008, Pages 4837-4843

  Roh, Danny S ^a   Cook, Amanda L ^a   Rhee, Steven S ^a   Joshi, Amar ^a   Kowalski, Regis ^a   Dhaliwal, Deepinder K ^a   Funderburgh, James L ^a  

^a University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GAMMA H2AX; HISTONE H2AX; LIPOCORTIN 5; MITOMYCIN C; UNCLASSIFIED DRUG; EYE DROPS; H2AFX PROTEIN, HUMAN; HISTONE; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITOR; PHOSPHOPROTEIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; COMET ASSAY; CONTROLLED STUDY; CORNEA CELL; CORNEA ENDOTHELIUM; DIFFUSION; DNA CROSS LINKING; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; DRUG EXPOSURE; ENDOTHELIUM CELL; ESCHERICHIA COLI; GOAT; GROWTH INHIBITION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; REFRACTIVE SURGERY; STAINING; ANIMAL; CELL COUNT; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; POSTOPERATIVE COMPLICATION;

ANIMALS; ANNEXIN A5; APOPTOSIS; CELL COUNT; CELLS, CULTURED; COMET ASSAY; DISEASE MODELS, ANIMAL; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, CORNEAL; GOATS; HISTONES; MITOMYCIN; NUCLEIC ACID SYNTHESIS INHIBITORS; OPHTHALMIC SOLUTIONS; PHOSPHOPROTEINS; PHOSPHORYLATION; POSTOPERATIVE COMPLICATIONS;

EID: 56149120917     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.08-2115     Document Type: Article

References (34)

1. Chabner BA, Amrein PC, Druker BJ, et al. Antineoplastic agents. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York: McGraw Hill; 2006.
2. Abraham LM, Selva D, Casson R, Leibovitch I. Mitomycin: clinical applications in ophthalmic practice. Drugs. 2006;66:321-340. (Pubitemid 46291768)
3. Majmudar PA, Forstot SL, Dennis RF, et al. Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. Ophthalmology. 2000;107:89-94.
4. Carones F, Vigo L, Scandola E, Vacchini L. Evaluation of the prophylactic use of mitomycin-C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg. 2002;28:2088-2095. (Pubitemid 36026085)
5. Lane HA, Swale JA, Majmudar PA. Prophylactic use of mitomycin-C in the management of a buttonholed LASIK flap. J Cataract Refract Surg. 2003;29:390-392.
6. Gambato C, Ghirlando A, Moretto E, Busato F, Midena E. Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. Ophthalmology. 2005;112:208-218; discussion 219. (Pubitemid 40202553)
7. Lee DH, Chung HS, Jeon YC, Boo SD, Yoon YD, Kim JG. Photorefractive keratectomy with intraoperative mitomycin-C application. J Cataract Refract Surg. 2005;31:2293-2298.
8. Lacayo GO 3rd, Majmudar PA. How and when to use mitomycin-C in refractive surgery. Curr Opin Ophthalmol. 2005;16:256-259.
9. Bedei A, Marabotti A, Giannecchini I, et al. Photorefractive keratectomy in high myopic defects with or without intraoperative mitomycin C: 1-year results. Eur J Ophthalmol. 2006;16:229-234. (Pubitemid 43874392)
10. Kim TI, Pak JH, Lee SY, Tchah H. Mitomycin C-induced reduction of keratocytes and fibroblasts after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2004;45:2978-2984. (Pubitemid 39121825)
11. Kim TI, Tchah H, Lee SA, Sung K, Cho BJ, Kook MS. Apoptosis in keratocytes caused by mitomycin C. Invest Ophthalmol Vis Sci. 2003;44:1912-1917.
12. Chang SW. Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. J Refract Surg. 2005;21:446-453.
13. Torres RM, Merayo-Lloves J, Daya SM, et al. Presence of mitomycin-C in the anterior chamber after photorefractive keratectomy. J Cataract Refract Surg. 2006;32:67-71. (Pubitemid 43330051)
14. Song JS, Kim JH, Yang M, Sul D, Kim HM. Mitomycin-C concentration in cornea and aqueous humor and apoptosis in the stroma after topical mitomycin-C application: effects of mitomycin-C application time and concentration. Cornea. 2007;26:461-467. (Pubitemid 46684388)
15. Song JS, Kim JH, Yang M, Sul D, Kim HM. Concentrations of mitomycin C in rabbit corneal tissue and aqueous humor after topical administration. Cornea. 2006;25:S20-S23. (Pubitemid 44454745)
16. Diakonis VF, Pallikaris A, Kymionis GD, Markomanolakis MM. Alterations in endothelial cell density after photorefractive keratectomy with adjuvant mitomycin. Am J Ophthalmol. 2007;144:99-103. (Pubitemid 46963194)
17. de Benito-Llopis L, Teus MA, Ortega M. Effect of mitomycin-C on the corneal endothelium during excimer laser surface ablation. J Cataract Refract Surg. 2007;33:1009-1013. (Pubitemid 46771079)
18. Goldsberry DH, Epstein RJ, Majmudar PA, et al. Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg. 2007;23:724-727.
19. Chang SW. Early corneal edema following topical application of mitomycin-C. J Cataract Refract Surg. 2004;30:1742-1750.
20. Morales AJ, Zadok D, Mora-Retana R, Martinez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol. 2006;142:400-404. (Pubitemid 44691754)
21. Sihota R, Sharma T, Agarwal HC. Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand. 1998;76:80-82.
22. Fukuchi T, Hayakawa Y, Hara H, Abe H. Corneal endothelial damage after trabeculectomy with mitomycin C in two patients with glaucoma with cornea guttata. Cornea. 2002;21:300-304. (Pubitemid 34250609)
23. Mietz H, Roters S, Krieglstein GK. Bullous keratopathy as a complication of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol. 2005;243:1284-1287. (Pubitemid 43055196)
24. Mohammadpour M, Jabbarvand M, Javadi MA. Focal corneal decompensation after filtering surgery with mitomycin C. Cornea. 2007;26:1285-1287. (Pubitemid 350190931)
25. McKenna DJ, Gallus M, McKeown SR, Downes CS, McKelvey-Martin VJ. Modification of the alkaline comet assay to allow simultaneous evaluation of mitomycin C-induced DNA cross-link damage and repair of specific DNA sequences in RT4 cells. DNA Repair. 2003;2:879-890. (Pubitemid 37297452)
26. Sedelnikova OA, Pilch DR, Redon C, Bonner WM. Histone H2AX in DNA damage and repair. Cancer Biol Ther. 2003;2:233-235.
27. Chowdhury D, Keogh MC, Ishii H, Peterson CL, Buratowski S, Lieberman J. Gamma-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair. Mol Cell. 2005;20:801-809. (Pubitemid 41740701)
28. Downey MDD. GammaH2AX as a checkpoint maintenance signal. Cell Cycle. 2006;5:1376-1381.
29. Inoki T, Endo H, Inoki Y, et al. Damaged DNA-binding protein 2 accelerates UV-damaged DNA repair in human corneal endothelium. Exp Eye Res. 2004;79:367-376. (Pubitemid 39164474)
30. McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2001;2:483-490. (Pubitemid 33586303)
31. Lawley PD, Phillips DH. DNA adducts from chemotherapeutic agents. Mutat Res. 1996;355:13-40.
32. Joyce NC. Proliferative capacity of the corneal endothelium. Prog Retin Eye Res. 2003;22:359-389.
33. Crawford KM, Ernst SA, Meyer RF, MacCallum DK. NaK-ATPase pump sites in cultured bovine corneal endothelium of varying cell density at confluence. Invest Ophthalmol Vis Sci. 1995;36:1317-1326.
34. Thornton I, Puri A, Xu M, Krueger RR. Low-dose mitomycin C as a prophylaxis for corneal haze in myopic surface ablation. Am J Ophthalmol. 2007;144:673-681. (Pubitemid 47614951)